Skip to main content

Advertisement

SpringerLink
Log in

Mucopolysaccharidosis type I therapy

  • Consultation Section
  • Published:
Annals of Ophthalmology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Cleary MA, Wraith JE. The presenting features of mucopolysaccharidosis type IH (Hurler syndrome). Acta Paediatr 1995;84:337–339.

    PubMed  CAS  Google Scholar 

  • Francois J. Ocular manifestations of the mucopolysaccharidoses. Ophthalmologica 1974;169:345–361

    Article  PubMed  CAS  Google Scholar 

  • Grewal SS, Wynn R, Abdenur JE, et al. Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome. Genet Med 2005;7:143–146.

    Article  PubMed  CAS  Google Scholar 

  • Wraith JE. The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I. Expert Opin Pharmacother 2005;6:489–506.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. La Paz, Bolivia

    Fernando H. Murillo-Lopez MD

Authors
  1. Fernando H. Murillo-Lopez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murillo-Lopez, F.H. Mucopolysaccharidosis type I therapy. Ann Ophthalmol 37, 235–236 (2005). https://doi.org/10.1385/AO:37:4:235

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/AO:37:4:235

Search

Navigation